Compare Merck & Co., Inc. (MRK) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Southern Copper Corp — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Southern Copper Corp trades at $209.21 (market cap $167.74B). The key difference: Merck & Co., Inc. is far larger — about 2.1× Southern Copper Corp's market cap, and Merck & Co., Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Southern Copper Corp for 61 Days on average.
| MRK | SCCO | |
|---|---|---|
Market Cap | $351.28B | $167.74B |
Volume | 7,969,665 | 853,110 |
Sector | Health | Basic Materials |
52-Week High | $156.43 | $219.70 |
52-Week Low | $82.49 | $120.02 |
Typical Hold Time | 98 Days | 61 Days |
Enterprise Value | $398.04B | $169.03B |
Dividend Yield | 2.39% | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal and key support at $140. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.14. Revenue grew to $65.01B in 2025, and net income reached $18.25B, though the P/E ratio is elevated at 113.9. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline.
The outlook for MRK is mixed, with solid fundamentals and analyst optimism countered by high valuation and bearish technicals. The consensus price target of $158.78 suggests upside potential, but investors face risks from competitive pressures and integration challenges from recent M&A activity. Earnings growth and pipeline developments remain key catalysts.
Southern Copper (SCCO) trades at $198.66, down 0.95% on the day amid bearish technical signals. The stock shows strong fundamentals with revenue growth from $13.42B in 2025 to projected $15.8B in 2026 and net income margins expanding to 35.87%. Recent earnings beats and a $10.2B Mexican project pipeline support long-term growth, though valuation ratios remain elevated with P/E at 29.81.
Outlook remains mixed with strong operational performance offset by premium valuation and bearish analyst sentiment. The stock trades above consensus price target of $167.67, presenting near-term downside risk. Long-term growth drivers from copper demand and expansion projects offer potential upside, but current levels warrant caution given technical weakness and divided analyst ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
